Drawing for XELTIS

USPTO serial 79229175

XELTIS

Reviewed by CopyMark Law Group

Reg. 5705877Status 739Registered
Filing date
Status date
Registration date
Mar 26, 2019
Examiner
TAYLOR, DAVID T
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with XELTIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erica Halstead

Erica Halstead Womble Bond Dickinson (US) LLP950 Third Ave; Suite 2400New York, NY 10022United States

Goods and services

ClassDescriptionStatusFirst use
010Cardiovascular implants, namely, prosthetic valves and artificial vascular graftsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 3, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jul 3, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 26, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Mar 26, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 24, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 9, 2021RNWLINTERNATIONAL REGISTRATION RENEWED—
Jun 5, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 16, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 26, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 26, 2019FIMPFINAL DISPOSITION PROCESSED—
Jun 26, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 26, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 8, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 8, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 19, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 4, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 7, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 7, 2018ALIEASSIGNED TO LIE—
Oct 29, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2018RFNTREFUSAL PROCESSED BY IB—
May 1, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 1, 2018RFRRREFUSAL PROCESSED BY MPU—
Apr 25, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 24, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 12, 2018DOCKASSIGNED TO EXAMINER—
Mar 31, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 27, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 26, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Mar 22, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance